- Home
- PAVM vs EVGN Comparison
PAVM vs EVGN Comparison
Compare PAVM & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVM
- EVGN
- Stock Information
- Founded
- PAVM 2014
- EVGN 1999
- Country
- PAVM United States
- EVGN Israel
- Employees
- PAVM N/A
- EVGN 75
- Industry
- PAVM Medical/Dental Instruments
- EVGN Agricultural Chemicals
- Sector
- PAVM Health Care
- EVGN Industrials
- Exchange
- PAVM Nasdaq
- EVGN Nasdaq
- Market Cap
- PAVM 12.0M
- EVGN 11.9M
- IPO Year
- PAVM 2016
- EVGN N/A
- Fundamental
- Price
- PAVM $0.59
- EVGN $1.35
- Analyst Decision
- PAVM Strong Buy
- EVGN Strong Buy
- Analyst Count
- PAVM 1
- EVGN 1
- Target Price
- PAVM $19.00
- EVGN $3.50
- AVG Volume (30 Days)
- PAVM 115.2K
- EVGN 114.6K
- Earning Date
- PAVM 08-11-2025
- EVGN 08-21-2025
- Dividend Yield
- PAVM N/A
- EVGN N/A
- EPS Growth
- PAVM N/A
- EVGN N/A
- EPS
- PAVM 0.96
- EVGN N/A
- Revenue
- PAVM $1,993,000.00
- EVGN $6,765,000.00
- Revenue This Year
- PAVM N/A
- EVGN N/A
- Revenue Next Year
- PAVM $455.63
- EVGN $113.18
- P/E Ratio
- PAVM $0.62
- EVGN N/A
- Revenue Growth
- PAVM N/A
- EVGN N/A
- 52 Week Low
- PAVM $0.54
- EVGN $0.95
- 52 Week High
- PAVM $1.90
- EVGN $6.30
- Technical
- Relative Strength Index (RSI)
- PAVM 44.90
- EVGN 50.87
- Support Level
- PAVM $0.58
- EVGN $1.32
- Resistance Level
- PAVM $0.62
- EVGN $1.38
- Average True Range (ATR)
- PAVM 0.03
- EVGN 0.07
- MACD
- PAVM 0.00
- EVGN -0.00
- Stochastic Oscillator
- PAVM 55.90
- EVGN 42.31
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.